BODY FAT REDUCTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Body Fat Reduction Market, By Treatment Modality (Non-Invasive Treatments, Minimally Invasive Treatments and Surgical Treatments), By Target Body Area (Abdomen, Thighs, Hips and Buttocks, Arms, and Multiple Body Areas), By End User (Dermatology Clinics, Plastic Surgery Clinics, Hospitals and Ambulatory Surgical Centers, and Medical Spas and Beauty Clinics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In March 2024, Amgen differentiated itself in the competitive weight loss market with its injectable treatment, MariTide, which not only aids in weight loss but also helps maintain weight loss after discontinuation
In April 2023, Eli Lilly and Company announced that tirzepatide (10 mg and 15 mg) demonstrated superior weight loss as compared to placebo over 72 weeks in the SURMOUNT-2 study. Participants using tirzepatide lost up to 15.7% of their body weight. This phase 3 trial, involving 938 adults with obesity or overweight and type 2 diabetes, met all primary and secondary objectives for efficacy and safety.
In February 2022, Givaudan introduced PrimeLock+, a patent-pending, natural, vegan-friendly solution designed to enhance plant-based products. It mimics animal fat cells to improve the taste, texture, and juiciness of plant-based foods, addressing common issues like oil loss during cooking. This innovation helps food manufacturers elevate consumer satisfaction by better preserving flavor and texture.
In May 2021, Allergan Aesthetics acquired Soliton, a company known for its rapid acoustic pulse device used in non-invasive treatments to temporarily enhance the appearance of cellulite. This acquisition broadened Allergan Aesthetics' range of body contouring treatments.